Arcus Biosciences Inc

8. okt 2026, 20:07 UTC

Arcus Biosciences Inc shares are declining, closing significantly lower since Wednesday and near the bottom of their one-month range after an earlier session pullback.

7. okt 2026, 19:46 UTC

Arcus Biosciences Inc shares are higher, having gained ground but remain below their 20-day moving average and near the lower end of their one-month range.

6. okt 2026, 20:30 UTC

Arcus Biosciences Inc's shares declined in after-market trading, currently at their lowest point of the day and well below the 20-day moving average.

5. okt 2026, 20:06 UTC

Arcus Biosciences Inc is advancing, supported by broader market movements, and has gained since Friday's close, despite earlier pulling back from a session high.

2. okt 2026, 20:02 UTC

Arcus Biosciences Inc shares fell sharply, reversing earlier gains, and remain below their 20-day moving average amid ongoing weakness.

1. okt 2026, 20:08 UTC

Nektar Therapeutics' disappointing Phase 2b study results contributed to a broader downturn in biotechnology, with the SPDR S&P Biotech ETF also lower.

30. sept 2026, 20:07 UTC

Arcus Biosciences Inc shares are advancing modestly as Wedbush reiterates its Outperform rating and maintains a $43 price target.

29. sept 2026, 20:07 UTC

Arcus Biosciences Inc is advancing, reflecting a notable increase since Monday's close, although it remains below its 20-day moving average.

28. sept 2026, 19:15 UTC

Arcus Biosciences Inc is advancing, having reached a notable peak today, despite trading below its 20-day moving average and three prior sessions closing lower.

25. sept 2026, 23:50 UTC

Arcus Biosciences Inc is trading lower in after-hours, reaching its lowest point of the day and remaining well below its 20-day moving average.

24. sept 2026, 20:01 UTC

Arcus Biosciences Inc shares fell sharply, continuing a downward trend from Wednesday's close and trading well below its 20-day moving average.

23. sept 2026, 20:07 UTC

Arcus Biosciences Inc shares fell amid a broader market downturn and rising U.S. Treasury yields, despite earlier reaching a session high.

22. sept 2026, 20:06 UTC

Arcus Biosciences Inc is advancing amid a strong biotechnology sector, gaining ground since Monday's close but remains below its 20-day moving average.

21. sept 2026, 19:16 UTC

Arcus Biosciences Inc is trading higher since Friday's close, despite being below its 20-day moving average and near the lower end of its one-month range.

18. sept 2026, 20:13 UTC

Arcus Biosciences Inc is advancing in after-market trading following Friday's close, despite being positioned below its 20-day moving average.

17. sept 2026, 19:36 UTC

Arcus Biosciences is advancing, building on prior momentum, amid a broader biotech sector uptick driven by positive Phase 3 results from Moderna's cancer vaccine trial.

16. sept 2026, 23:06 UTC

Arcus Biosciences Inc is trading slightly higher in after-market hours, recovering from an earlier dip but remains below its 20-day moving average.

15. sept 2026, 19:36 UTC

RCUS lower today, tracking declines in SPDR S&P Biotech ETF.

14. sept 2026, 20:21 UTC

Arcus Biosciences Inc shares are lower in after-market hours, marking seven consecutive sessions of declines. No specific news was identified for the price movement.

11. sept 2026, 21:21 UTC

Arcus Biosciences Inc shares are lower in after-market trading, continuing a recent trend. No specific company news was identified to explain the decline.

10. sept 2026, 20:01 UTC

Arcus Biosciences Inc shares are sharply lower today, breaking a recent trend of higher closes. Unusually high trading volume may be influencing the decline.

9. sept 2026, 20:07 UTC

Shares of Arcus Biosciences are lower today, despite anticipation of a significant data update in October following a recent presentation at Citigroup's summit.

8. sept 2026, 20:07 UTC

Arcus Biosciences Inc shares are lower today, continuing a decline since Friday's close. The stock is trading near the lower end of its one-month range.

2. sept 2026, 20:08 UTC

Arcus Biosciences Inc. shares are higher today, supported by gains in the biotechnology sector and trends in related ETFs. The stock has stabilized after fluctuations.

28. aug 2026, 20:02 UTC

Arcus Biosciences shares are lower today, breaking a trend of higher closes. Rising U.S. Treasury yields may be impacting investor sentiment in biotechnology.

26. aug 2026, 20:08 UTC

Arcus Biosciences Inc shares are lower during Wednesday's session amid mixed market performance and inflation data, with no specific company news identified for the decline.

20. aug 2026, 19:36 UTC

Arcus Biosciences shares are lower, reflecting a broader decline in the biotechnology sector amid first-quarter results indicating a notable drop in price.

19. aug 2026, 19:46 UTC

Arcus Biosciences Inc is trading higher, supported by a positive trend in the biotechnology sector. The stock remains above its 20-day moving average.

18. aug 2026, 20:06 UTC

Arcus Biosciences Inc. shares are trading roughly flat amid no specific news. The stock remains above its 20-day moving average.

17. aug 2026, 19:16 UTC

Arcus Biosciences Inc is rising as biotechnology sector momentum continues. The company reported second-quarter revenue of $41 million and a net loss of $91 million.